Features of Cardiac Allograft Coronary Endothelial Dysfunction-Reference-Cited by-同舟云学术

Features of Cardiac Allograft Coronary Endothelial Dysfunction

Published:2009-04 Issue:8 Volume:103 Page:1154-1158
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Raichlin Eugenia,Kushwaha Sudhir S.,Lennon Ryan J.,Frantz Robert P.,Edwards Brooks S.,Prasad Abhiram,Rihal Charanjit S.,Lerman Amir

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death;Hollenberg;Circulation,2001

2. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant;Davis;Circulation,1996

3. Nitric oxide and endothelin in the development of cardiac allograft vasculopathy;Liu;Atherosclerosis,1998

4. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation;Hollenberg;J Heart Lung Transplant,1998

5. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries;Wolford;Circulation,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated Heart Rate Following Heart Transplantation Is Associated With Increased Graft Vasculopathy and Mortality;Journal of Cardiac Failure;2019-04

2. Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy;Current Vascular Pharmacology;2012-03-01

3. Mechanism of arterial remodeling in chronic allograft vasculopathy;Frontiers of Medicine;2011-09

4. Nitric Oxide-Mediated Coronary Flow Regulation in Patients with Coronary Artery Disease: Recent Advances;International Journal of Angiology;2011-07-04

5. The Usefulness of Chronic Heart Failure Treatments in Chronic Cardiac Graft Failure;Cardiovascular Therapeutics;2010-02